CMS Open Payments · Program Year 2024
Gotham Surgical Solutions & Devices, Inc.
Gotham Surgical Solutions & Devices, Inc. reported $164,927.60 across General Payments, Research, and Ownership to 245 physicians and teaching hospitals across 245 transactions.
- $164.9K
- All-tracks total
- 245
- Transactions
- 245
- Recipients
- +$50.9K
- General Payments vs PY2023
Gotham Surgical Solutions & Devices, Inc. reported $164,927.60 across all CMS Open Payments tracks (General + Research + Ownership) to 245 physicians and teaching hospitals in Program Year 2024 - ranking #1056 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $164,927.60, averaging $673.17 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer gotham-surgical-solutions-devices-inc Gotham Surgical Solutions & Devices, Inc.
$164.9K · #1056/1,925 · 0.0% industry · PY2024
- TOT $164.9K
- RANK #1056
- SHARE 0.0%
- TXN 245
- RCP 245
- CAT 3
- GEN $164.9K
- ΔGEN +$50.9K
- TOP1 44.1%
- PY 2024
Volume peers
Nearest volume peer: SweetBio, Inc. ($165.0K)
Gotham Surgical Solutions & Devices, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Gotham Surgical Solutions & Devices, Inc.'s CMS-reported General Payments increased by $50.9K (+44.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: GOTHAM SURGICAL SOLUTIONS & DEVICES, INC.PY2023: GOTHAM SURGICAL SOLUTIONS & DEVICES, INC.PY2024: Gotham Surgical Solutions & Devices, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $114,021.64
- PY2024
- $164,927.60
What the Data Shows for Gotham Surgical Solutions & Devices, Inc.
Rank #1056 of 1,925 companies in CMS Open Payments for 2024 belongs to Gotham Surgical Solutions & Devices, Inc., which reported $164,927.60 across 245 transactions to 245 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $673.17 per transaction and $673.17 per recipient.
The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $145.3K, accounting for 88.1% of this company's General Payments and 26 transactions.
General Payment Breakdown by Type
Gotham Surgical Solutions & Devices, Inc. made 3 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $145.3K, 88.1% of General Payments.
How Gotham Surgical Solutions & Devices, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $145.3K | 26 | 88.1% |
| Food and Beverage | $15.7K | 202 | 9.5% |
| Travel and Lodging | $3.9K | 17 | 2.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $147,800.40 (89.6%) of $164,927.60 in this company's General Payments records across 116 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Gotham Surgical Solutions & Devices, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Christopher Fx Riegler
$72,651.89 across 13 reported transactions
- 2
Stephen J Nicholas
$72,651.89 across 13 reported transactions
- 3
Jeremy Mangion
$1,000.24 across 6 reported transactions
- 4
Rachel Talley-Bruns
$779.57 across 8 reported transactions
- 5
Deborah Allen
$716.81 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Gotham Surgical Solutions & Devices, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Gotham Surgical Solutions & Devices, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Gotham Surgical Solutions & Devices, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
BK Medical Holding Company Inc.
Resmed Corp
Lumendi LLC
B. Braun Melsungen AG
Bioprotect Medical, Inc.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.